EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration

Roberta Cassano iD, Roberta Sole, Carlo Siciliano iD, Noemi Baldino iD, Olga Mileti, Debora Procopio iD, Federica Curcio, Gabriella Calviello, Simona Serini, Sonia Trombino iD, Maria Luisa Di Gioia iD

Pharmaceutics · 04.12.2024 · 16 (12) · 1552

DOI: 10.3390/pharmaceutics16121552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 04.12.2024. Verfasst von Roberta Cassano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Farmacia, Salute e Scienze della Nutrizione, Università della Calabria, Arcavacata di Rende, 87036 Cosenza, Italy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol belongs to Class III, characterized by high solubility but low permeability. Currently, atenolol is commercially available in oral formulations. Increasing attention is being directed towards developing cost-effective transdermal delivery systems, due to their ease of use and better patient compliance. Eutectogels represent next-generation systems that are attracting great interest in the scientific community. Typically obtained from deep eutectic solvents (DESs) combined with gelling agents, these systems exhibit unique properties due to the intrinsic characteristics of DESs.

Methods

In this study, a DES based on choline chloride as a hydrogen bond acceptor (HBA) and propylene glycol as a hydrogen bond donor (HBD) was explored to enhance the topical delivery of atenolol. The solubility of atenolol in the DES was evaluated using spectroscopic and thermodynamic measurements which confirmed the formation of hydrogen bonds between the drug and DES components. Additionally, the safety of the DES was assessed in a cell viability assay. Subsequently, we formulated eutectogels with different concentrations using animal gelatin and Tego Carbomer 140, and characterized these formulations through rheological measurements, swelling percentage, and permeation studies with Franz cells.

Results

These novel eutectogels exhibit superior performance over conventional hydrogels, with a release rate of approximately 86% and 51% for Carbomer- and gelatin-based eutectogels, respectively. In contrast, comparable hydrogels released only about 27% and 35%.

Conclusions

These findings underscore the promising potential of eutectogels for the transdermal delivery of atenolol.

Schlagwörter

Stichwörter der Autor:innen

antihypertensive drugsatenololdeep eutectic solventsdrug deliveryeutectogelgreen solventsβ-blockers

Autor:innen und Institutionen

  • Dipartimento di Farmacia, Salute e Scienze della Nutrizione, Università della Calabria, Arcavacata di Rende, 87036 Cosenza, Italy.
  • Dipartimento di Ingegneria Informatica, Modellistica, Elettronica e Sistemistica, Università della Calabria, Arcavacata di Rende, 87036 Cosenza, Italy.
  • Dipartimento di Medicina e Chirurgia Traslazionale, Sezione di Patologia Generale, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Largo F. Vito, 00168 Roma, Italy.
  • Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito, 00168 Roma, Italy.

ORCID-Profile: Roberta Cassano, Carlo Siciliano, Noemi Baldino, Debora Procopio, Sonia Trombino, Maria Luisa Di Gioia

Zitieren

APA

Cassano, R., Sole, R., Siciliano, C., Baldino, N., Mileti, O., Procopio, D., Curcio, F., Calviello, G., Serini, S., Trombino, S., & Di Gioia, M. L. (2024). Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration. Pharmaceutics, 16(12), 1552. https://doi.org/10.3390/pharmaceutics16121552

Vancouver

Cassano R, Sole R, Siciliano C, Baldino N, Mileti O, Procopio D, et al. Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration. Pharmaceutics. 2024;16(12):1552. doi:10.3390/pharmaceutics16121552

BibTeX
@article{Cassano2024,
  author = {Cassano, Roberta and Sole, Roberta and Siciliano, Carlo and Baldino, Noemi and Mileti, Olga and Procopio, Debora and Curcio, Federica and Calviello, Gabriella and Serini, Simona and Trombino, Sonia and Di Gioia, Maria Luisa},
  title = {Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1552},
  doi = {10.3390/pharmaceutics16121552}
}
Kostenlos starten →